Pages that link to "Q43466373"
Jump to navigation
Jump to search
The following pages link to Low bone mass and severity of cholestasis affect fracture risk in patients with primary biliary cirrhosis. (Q43466373):
Displaying 33 items.
- Bisphosphonates for osteoporosis in primary biliary cirrhosis (Q24234283) (← links)
- Bisphosphonates for osteoporosis in primary biliary cirrhosis (Q24234967) (← links)
- Classical and Emerging Roles of Vitamin D in Hepatitis C Virus Infection (Q24561964) (← links)
- Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis: a Review Featuring a Women's Health Perspective (Q26781780) (← links)
- Osteoporosis and fractures in liver disease: relevance, pathogenesis and therapeutic implications (Q26824690) (← links)
- Management of endocrine disease: Secondary osteoporosis: pathophysiology and management (Q26998249) (← links)
- Diagnosis and Management of Cirrhosis-Related Osteoporosis (Q28069053) (← links)
- Modeling hepatic osteodystrophy in Abcb4 deficient mice (Q33824596) (← links)
- Osteoporosis in primary biliary cirrhosis of the liver (Q33941359) (← links)
- Effects of cyclosporin-a on rat skeletal biomechanical properties (Q34056813) (← links)
- Osteoporosis and gastrointestinal disease (Q34178759) (← links)
- Bone Disease in Patients With Primary Sclerosing Cholangitis (Q34597311) (← links)
- The impact of fragility fractures on health-related quality of life in patients with primary sclerosing cholangitis (Q35589931) (← links)
- Sex differences associated with primary biliary cirrhosis. (Q36014535) (← links)
- Strengthening the bones in primary biliary cirrhosis (Q37375972) (← links)
- Osteodystrophy in chronic liver diseases (Q37975457) (← links)
- Hepatitis C virus infection and risk of osteoporosis: A meta-analysis (Q38672659) (← links)
- Osteoporosis across chronic liver disease. (Q38723451) (← links)
- Ursodeoxycholic acid decreases bilirubin-induced osteoblast apoptosis (Q38946483) (← links)
- Ursodeoxycholic acid increases differentiation and mineralization and neutralizes the damaging effects of bilirubin on osteoblastic cells. (Q39170726) (← links)
- Effects of bilirubin and sera from jaundiced patients on osteoblasts: contribution to the development of osteoporosis in liver diseases. (Q39491198) (← links)
- Risk and adverse outcomes of fractures in patients with liver cirrhosis: two nationwide retrospective cohort studies (Q42376792) (← links)
- Chronic CCl4 intoxication causes liver and bone damage similar to the human pathology of hepatic osteodystrophy: a mouse model to analyse the liver-bone axis (Q42707672) (← links)
- Hepatitis C virus infection and risk of osteoporotic fracture: A systematic review and meta-analysis. (Q47555545) (← links)
- Randomized trial comparing monthly ibandronate and weekly alendronate for osteoporosis in patients with primary biliary cirrhosis. (Q50480283) (← links)
- The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines. (Q52624982) (← links)
- Sclerostin Expression in Bile Ducts of Patients With Chronic Cholestasis May Influence the Bone Disease in Primary Biliary Cirrhosis. (Q53137198) (← links)
- Guidelines for the management of primary biliary cirrhosis (Q56429943) (← links)
- Osteoporosis in primary biliary cholangitis (Q57168372) (← links)
- Hepatic Osteodystrophy-Molecular Mechanisms Proposed to Favor Its Development. (Q64998522) (← links)
- Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation (Q87644212) (← links)
- Diffusion-weighted MRI for detection of hepatic osteodystrophy in primary sclerosing cholangitis: a comparison study with dual-energy X-ray absorptiometry (Q88061881) (← links)
- Osteoporosis in Primary Biliary Cholangitis: Prevalence, Impact and Management Challenges (Q89538006) (← links)